Mevalonate pathway promotes liver cancer by suppressing ferroptosis through CoQ10 production and selenocysteine-tRNA modification.
Chen Y, Lee D, Kwan KK, Wu M, Wang G, Zhang MS, Deng H, Cheu JW, Lau MH, Chan CYK, Ooi ZY, Wu Y, Bao MH, Lo RC, Ng IO, Wong CM, Wong CC.
Chen Y, et al. Among authors: zhang ms.
J Hepatol. 2025 Jul 11:S0168-8278(25)02335-9. doi: 10.1016/j.jhep.2025.06.034. Online ahead of print.
J Hepatol. 2025.
PMID: 40653112